Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Non-cash Items (2023 - 2025)

Fractyl Health's Non-cash Items history spans 3 years, with the latest figure at $6.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 7558.8% year-over-year to $6.7 million, compared with a TTM value of $6.7 million through Dec 2025, up 7558.8%, and an annual FY2025 reading of $6.7 million, up 5.88% over the prior year.
  • Non-cash Items for Q4 2025 was $6.7 million at Fractyl Health, up from $87000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $57.2 million in Q4 2023, with the low at $87000.0 in Q4 2024.
  • Average Non-cash Items over 3 years is $21.3 million, with a median of $6.7 million recorded in 2025.
  • Year-over-year, Non-cash Items plummeted 99.85% in 2024 and then skyrocketed 7558.8% in 2025.
  • Tracing GUTS's Non-cash Items over 3 years: stood at $57.2 million in 2023, then plummeted by 99.85% to $87000.0 in 2024, then skyrocketed by 7558.8% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Non-cash Items are $6.7 million (Q4 2025), $87000.0 (Q4 2024), and $57.2 million (Q4 2023).